Ching-Liang Ho Selected Research

Ching-Liang Ho Research Topics

Disease

38	Neoplasms (Cancer) 03/2023 - 12/2002
8	Breast Neoplasms (Breast Cancer) 03/2020 - 07/2004
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2011
6	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2004
6	Disease Progression 12/2021 - 06/2006
5	Adenocarcinoma 01/2023 - 09/2011
5	Colonic Neoplasms (Colon Cancer) 05/2021 - 08/2010
5	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 03/2002
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 01/2005
4	Multiple Myeloma 01/2019 - 01/2015
4	Primary Myelofibrosis (Myelosclerosis) 01/2012 - 01/2005
3	Lymphoma (Lymphomas) 01/2024 - 02/2003
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2023 - 06/2015
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2016
3	Hepatitis B 12/2021 - 11/2011
3	Colorectal Neoplasms (Colorectal Cancer) 06/2021 - 08/2010
3	Leukemia 01/2021 - 01/2013
3	Carcinoma (Carcinomatosis) 01/2021 - 02/2014
3	Invasive Fungal Infections 01/2018 - 08/2016
3	Neutropenia 01/2018 - 09/2015
3	Adenocarcinoma of Lung 01/2015 - 05/2012
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2005 - 12/2002
2	Pleural Effusion (Pleural Effusions) 10/2023 - 05/2012
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023 - 10/2021
2	Squamous Cell Carcinoma of Head and Neck 11/2022 - 12/2020
2	Thyroid Neoplasms (Thyroid Cancer) 02/2022 - 01/2022
2	COVID-19 02/2022 - 01/2020
2	Hepatocellular Carcinoma (Hepatoma) 12/2021 - 01/2019
2	Viremia 12/2021 - 11/2011
2	Fibrosis (Cirrhosis) 12/2021 - 09/2009
2	Hepatitis C 12/2021 - 01/2019
2	Myeloproliferative Disorders (Myeloproliferative Disorder) 10/2021 - 10/2007
2	Carcinogenesis 02/2021 - 05/2007
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 01/2020
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019 - 09/2002
2	Diabetes Mellitus 01/2019 - 11/2018
2	Fever (Fevers) 01/2018 - 08/2010
2	Lung Neoplasms (Lung Cancer) 08/2017 - 09/2011
2	Exanthema (Rash) 04/2014 - 04/2010
2	Sarcoma (Soft Tissue Sarcoma) 10/2012 - 09/2009
2	Polycythemia Vera 01/2012 - 10/2007
2	Essential Thrombocythemia 01/2012 - 10/2007
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2005 - 02/2003
1	Cytokine Release Syndrome 10/2023
1	Chylothorax 10/2023
1	Thrombosis (Thrombus) 03/2023
1	Animal Disease Models 04/2022
1	Circulating Neoplastic Cells 04/2022

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2008
10	ErbB Receptors (EGF Receptor)IBA 01/2022 - 09/2011
9	Biomarkers (Surrogate Marker)IBA 11/2022 - 07/2004
5	Tyrosine Kinase InhibitorsIBA 10/2021 - 09/2011
5	Cisplatin (Platino)FDA LinkGeneric 12/2020 - 04/2010
5	CytokinesIBA 01/2019 - 02/2003
4	Indicators and Reagents (Reagents)IBA 01/2023 - 07/2004
4	Fluorouracil (Carac)FDA LinkGeneric 12/2021 - 03/2018
4	TegafurIBA 11/2021 - 01/2017
4	UracilIBA 11/2021 - 01/2017
4	Gefitinib (Iressa)FDA Link 06/2015 - 09/2011
3	RNA (Ribonucleic Acid)IBA 01/2023 - 08/2016
3	Rituximab (Mabthera)FDA Link 05/2019 - 06/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2005 - 12/2002
2	AntigensIBA 01/2023 - 02/2022
2	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2022
2	AfatinibIBA 01/2022 - 05/2012
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2021 - 04/2010
2	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 11/2011
2	Monoclonal AntibodiesIBA 10/2021 - 07/2004
2	Polysaccharides (Glycans)IBA 01/2019 - 01/2019
2	Bortezomib (Velcade)FDA Link 01/2019 - 02/2018
2	posaconazole FDA Link 01/2018 - 08/2016
2	antroquinonolIBA 11/2015 - 10/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2015 - 04/2010
2	Carcinoembryonic AntigenIBA 01/2015 - 10/2014
2	Tartrate-Resistant Acid PhosphataseIBA 01/2011 - 07/2004
2	EnzymesIBA 04/2010 - 05/2007
2	ParaffinIBA 01/2005 - 03/2002
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 02/2003 - 12/2002
1	obinutuzumabIBA 01/2024
1	Chimeric Antigen ReceptorsIBA 10/2023
1	tocilizumab (atlizumab)FDA Link 10/2023
1	Triglycerides (Triacylglycerol)IBA 10/2023
1	AnticoagulantsIBA 03/2023
1	Vitamin K FDA Link 03/2023
1	CarbohydratesIBA 01/2023
1	5- iodo- 3- ((3,5- dibromo- 4- hydroxyphenyl)methylene)- 2- indolinoneIBA 04/2022
1	Sorafenib (BAY 43-9006)FDA Link 04/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 02/2022

Therapy/Procedure

26	Therapeutics 10/2023 - 09/2002
12	Drug Therapy (Chemotherapy) 11/2022 - 01/2005
5	Adjuvant Chemotherapy 01/2023 - 01/2015
5	Radiotherapy 01/2023 - 01/2005
5	Palliative Care (Palliative Therapy) 01/2021 - 09/2009
2	Precision Medicine 11/2022 - 02/2022
2	Chemoradiotherapy 11/2021 - 11/2019
2	Maintenance Chemotherapy 11/2021 - 11/2019
2	Transplantation 02/2018 - 01/2015
2	Combination Drug Therapy (Combination Chemotherapy) 02/2014 - 10/2013
1	Aftercare (After-Treatment) 10/2023
1	Intravenous Administration 10/2023